Skip to main content
. 2019 Oct 2;33(8):e22966. doi: 10.1002/jcla.22966

Figure 3.

Figure 3

5‐year survival curves of breast cancer patients. The 5‐year survival rate of patients with low or normal expression of miR‐205‐3p is significantly higher than that in patients with high expression of miR‐205‐3p